抗慢性乙型肝炎肝纤维化中成药研究进展

Research Progress of Anti-chronic Hepatitis B Liver Fibrosis Chinese Patent Medicine

肝纤维化指的是肝脏细胞外基质的弥漫性过度沉积和异常分布。在我国,慢性乙型肝炎是导致肝纤维化的主要原因。乙肝肝纤维化可进一步进展为肝硬化和肝癌。中医药在治疗乙肝及肝纤维化方面具有显著优势。本文就近年中医药抗肝纤维化的相关研究进行综述。

Hepatic fibrosis refers to the diffuse excessive deposition and abnormal distribution of liver extracellular matrix.In China,chronic hepatitis B is the main cause of liver fibrosis.Hepatitis B liver fibrosis can further progress to cirrhosis and liver cancer.Traditional Chinese medicine has obvious advantages in the treatment of hepatitis B and liver fibrosis.This paper reviews the related research on anti-hepatic fibrosis of traditional Chinese medicine in recent years.